Education
About Us
Working with TipRanks
Follow Us
Tempest Therapeutics (TPST)
NASDAQ:TPST
Bevacizumab, Atezolizumab, Tpst-1120
Hepatocellular Carcinoma (Hcc)
Phase III
Not Yet Recruiting
A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy
Nov 04, 2024
―
Atezolizumab, Nkt2152, Adg126, Tocilizumab, Tpst-1120, Tiragolumab, Bevacizumab 10 Mg/Kg, Bevacizumab 15 Mg/Kg, Tobemstomig 2100 Mg, Tobemstomig 600 Mg, Tobemstomig 1200 Mg, Io-108 1800 Mg, Io-108 1200 Mg
Advanced Liver Cancers
Phase I/II
Recruiting
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
Aug 21, 2020
―
Pembrolizumab, Tpst-1495 Twice Daily, Tpst-1495 Once Daily Or On Intermittent Schedule
Urothelial Carcinoma, Colorectal Cancer, Non Small Cell Lung Cancer, Solid Tumor, Endometrial Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Squamous Cell Carcinoma Of Head And Neck, Solid Tumors With Pik3ca Mutation
Phase I
Completed
Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors
Apr 07, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Tempest Therapeutics (TPST) have in its pipeline
TPST is currently developing the following drugs: Bevacizumab, Atezolizumab, Tpst-1120, Atezolizumab, Nkt2152, Adg126, Tocilizumab, Tpst-1120, Tiragolumab, Bevacizumab 10 Mg/Kg, Bevacizumab 15 Mg/Kg, Tobemstomig 2100 Mg, Tobemstomig 600 Mg, Tobemstomig 1200 Mg, Io-108 1800 Mg, Io-108 1200 Mg, Pembrolizumab, Tpst-1495 Twice Daily, Tpst-1495 Once Daily Or On Intermittent Schedule. These drug candidates are in various stages of clinical development as the company works toward FDA approval.